Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-03-09

Clinical Trial Update: TAR-0520 Gel in Hand and Foot Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for TAR-0520 Gel in hand and foot syndrome; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TAR-0520 Gel (TAR-0520)

Snippet

Sponsor: Tarian Pharma | Conditions: Hand and Foot Syndrome | Phase 2 | Status: NOT_YET_RECRUITING